Drug class
Cannabinoids
Mechanism of action
UGT1A9 Inhibitors [MoA]
General use cases
- Anxiety
- Epilepsies, Myoclonic
- Pain
- Lennox Gastaut Syndrome
- seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
